ARCHIVES

In Brief: Final appropriations for NCI Still Probably $875 Million; US-USR Drug Book Available

This article is from The Cancer Letter archive.

Vol. 03 No. 26 | July 1, 1977

Download PDF Visit The Full Archive

Related Articles

Tamoxfin Trial accrues 6,000, Problems with Minority accrual Remain

April 2, 1993

Cancer Rates May Rise 50% By 2020, IARC Says

April 18, 2003

BioMedicines Begins Kidney Cancer Study; EntreMed Moves Forward.

February 25, 2000

BSA Eliminates Second Review For P01 Grants; R01Payline To increase to 24th Percentile

November 23, 1997

Professional Societies: FASEB Urges Increase Of 15% For NIH, Double In Five Years

March 6, 1998

Also in this 8-page issue: NIH opens 240-bed Hatfield Clinical Research Center.

September 24, 2004